Diabetes Care
Gliclazide ER & Metformin Hydrochloride ER
| Brand | Ixizide-M XR 60/500 |
|---|---|
| Generic name | Gliclazide ER & Metformin Hydrochloride ER |
| Release type | Extended-release (ER) |
| Composition | Gliclazide ER 60 mg + Metformin HCl ER 500 mg |
| Therapeutic area | Diabetes Care |
Composition as stated in IXIA product literature:
| Ingredient | Strength |
|---|---|
| Gliclazide (extended-release) | 60 mg |
| Metformin Hydrochloride (extended-release) | 500 mg |
Ixizide-M XR 60/500 combines extended-release gliclazide, a sulfonylurea, with extended-release metformin hydrochloride, a biguanide, in a lower metformin strength than Ixizide-M XR 60/1000. It is part of the IXIA Healthcare diabetes care range.
IXIA product literature positions the Ixizide range for glycaemic control in diabetes care. For approved indications and dosage, refer to the prescribing information supplied with the product and the advice of the treating physician.
Refer to the storage instructions printed on the pack. Keep the medicine out of reach of children.
For availability, trade information or product literature on Ixizide-M XR 60/500, contact our team.
For healthcare professionals
Use this medicine only under the guidance of a registered medical practitioner. Information on this page is for general reference and does not replace professional medical advice.
Diabetes Care
Gliclazide ER 60 mg + Metformin HCl ER 1000 mg
Extended-release tablet · 10 x 15 tablets
Diabetes Care
Gliclazide ER 60 mg
Extended-release (ER)
Pain & Inflammation
Aceclofenac 100 mg + Paracetamol 325 mg
Tablet · 10 x 10 tablets
